The hallmark of PEComa diagnosis is the co-expression of melanocytic markers (such as HMB45, Melan-A) and smooth muscle markers (such as SMA, desmin). This evidence concerns the gene MLANA and neoplasm with perivascular epithelioid cell differentiation.